Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 983 products on this category.

Product data	Purity	Price range	Estimated delivery
N2-Nitroso Levofolinic Acid REF: 4Z-F-068034	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 35 REF: 4Z-O-032040	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 50 REF: 4Z-C-121053	- - -	To inquire	Tue 17 Dec 24
Palbociclib Impurity 40 REF: 4Z-P-196047	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 62 REF: 4Z-C-121065	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 28 REF: 4Z-N-066044CAS: 855860-75-2	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 29 REF: 4Z-L-124034	- - -	To inquire	Tue 17 Dec 24
Palbociclib Impurity 79 REF: 4Z-P-196089CAS: 2768689-12-7 571189-64-5	- - -	To inquire	Tue 17 Dec 24
Gimeracil Impurity 12 REF: 4Z-G-047014	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 89 REF: 4Z-N-066102	- - -	To inquire	Tue 17 Dec 24
Sodium Dichloroisocyanurate REF: 4Z-G-047022CAS: 1260366-40-2 2782-57-2 2893-78-9	- - -	To inquire	Tue 17 Dec 24
Folinic Acid Impurity 5 (4-Aminobenzoyl D-Glutamic Acid) REF: 4Z-F-068014CAS: 5959-18-2	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 47 REF: 4Z-E-068060CAS: 2029195-97-7	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 17 (Intedanib Impurity 17) REF: 4Z-N-066031	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 40 REF: 4Z-N-066058CAS: 78466-25-8	- - -	To inquire	Tue 17 Dec 24
N-Nitroso Palbociclib Impurity 11 REF: 4Z-P-196086	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 26 REF: 4Z-N-066042	- - -	To inquire	Tue 17 Dec 24
Gimeracil Impurity 18 REF: 4Z-G-047021	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 43 REF: 4Z-E-068056CAS: 392-09-6	- - -	To inquire	Tue 17 Dec 24
Abiraterone Impurity 31 REF: 4Z-A-8281CAS: 23930-63-4	- - -	To inquire	Tue 17 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

N2-Nitroso Levofolinic Acid

Ref: 4Z-F-068034

Olaparib Impurity 35

Ref: 4Z-O-032040

Carfilzomib Impurity 50

Ref: 4Z-C-121053

Palbociclib Impurity 40

Ref: 4Z-P-196047

Carfilzomib Impurity 62

Ref: 4Z-C-121065

Nintedanib Impurity 28

Ref: 4Z-N-066044

Lenvatinib Impurity 29

Ref: 4Z-L-124034

Palbociclib Impurity 79

Ref: 4Z-P-196089

Gimeracil Impurity 12

Ref: 4Z-G-047014

Nintedanib Impurity 89

Ref: 4Z-N-066102

Sodium Dichloroisocyanurate

Ref: 4Z-G-047022

Folinic Acid Impurity 5 (4-Aminobenzoyl D-Glutamic Acid)

Ref: 4Z-F-068014

Enzalutamide Impurity 47

Ref: 4Z-E-068060

Nintedanib Impurity 17 (Intedanib Impurity 17)

Ref: 4Z-N-066031

Nintedanib Impurity 40

Ref: 4Z-N-066058

N-Nitroso Palbociclib Impurity 11

Ref: 4Z-P-196086

Nintedanib Impurity 26

Ref: 4Z-N-066042

Gimeracil Impurity 18

Ref: 4Z-G-047021

Enzalutamide Impurity 43

Ref: 4Z-E-068056

Abiraterone Impurity 31

Ref: 4Z-A-8281